Abstract
The top managers of the new DuPont laid out their vision for the company at an investor day in New York City on Nov. 8. A major difference between the future DuPont—which is set to separate from DowDuPont on June 1 of next year—and the one that merged with Dow last year is a more conservative approach to R&D and capital spending. “This company is being run very, very differently than it was being run three or four years ago,” Ed Breen, CEO of DowDuPont and future chairman of the new DuPont, told the stock analysts. The new DuPont will have four main lines of business: electronic materials, nutrition and biosciences, transportation and advanced polymers, and safety and construction. These businesses together had $21 billion in sales and $5.3 billion in earnings before taxes last year. Two-thirds of its portfolio comes from the old DuPont, but it picked up some
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
